Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance) Meeting Abstract
| Authors: | Dercle, L.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Luk, L.; Liu, A.; Yang, H.; Wen, Y.; Zhao, B.; Bertagnolli, M. M.; Meyerhardt, J. A.; O'Reilly, E. M.; Venook, A. P.; Schwartz, L. H.; Abou-Alfa, G. K. |
| Abstract Title: | Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance) |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800361 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.343 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 343 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
